FDA has questions about Merck's experimental chronic cough drug
January 24, 2022 at 12:13 PM EST
The chronic cough drug was approved in Japan, where it will be marketed under the brand name Lyfnua.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|